Clinical Report: Cryopreserved Amniotic Membrane in Oculoplastic Surgery

Overview

Cryopreserved amniotic membrane (CAM) transplantation offers significant advantages in oculoplastic surgery due to its anti-inflammatory, anti-scarring, and regenerative properties. CAM is particularly effective in complex eyelid and orbital reconstructions, providing biological activity and structural support without donor-site morbidity.

Background

Oculoplastic surgery often requires delicate tissue reconstruction, where traditional grafts like mucous membrane or skin grafts may have limitations such as donor-site morbidity or poor tissue compatibility. CAM transplantation has emerged as a valuable alternative, preserving key biological components that promote healing and reduce inflammation. The FDA currently recognizes BioTissue Ocular’s CAM360 as the only CAM product approved for oculoplastic use. CAM’s pliability, tensile strength, and biological activity make it especially suitable for treating cicatricial diseases, socket contracture, and implant exposure.

Data Highlights

Key distinctions in amniotic membrane preparations include thickness and processing method. Thicker, umbilical-cord-derived CAMs provide greater tensile strength for oculoplastic applications, while cryopreservation preserves anti-inflammatory and antifibrotic factors better than dehydration. CAM requires low-temperature storage, unlike dehydrated membranes. Surgical techniques involve securing CAM with full-thickness sutures anchored to periosteum and temporary tarsorrhaphy to support healing.

Key Findings

• Cryopreserved AM preserves heavy-chain hyaluronic acid/pentraxin 3 complex, conferring anti-inflammatory and anti-scarring effects.
• CAM eliminates donor-site morbidity associated with mucous membrane harvesting, improving patient comfort and reducing complications.
• Thicker, umbilical-cord-derived CAMs provide structural support for eyelid and orbital reconstruction, including fornix deepening and implant exposure prevention.
• Cryopreservation maintains biological activity better than dehydrated membranes, which lose growth factors and are more fragile after rehydration.
• CAM is easier to handle and manipulate intraoperatively compared to other graft types, facilitating complex reconstructive procedures.
• Use of CAM in cicatricial entropion and socket contracture supports epithelialization, reduces fibrosis, and improves functional and cosmetic outcomes.

Clinical Implications

CAM transplantation should be considered a first-line grafting option in complex oculoplastic reconstructions due to its biological advantages and ease of use. Its ability to reduce postoperative inflammation and scarring can improve healing and patient comfort, especially in challenging cases such as Stevens-Johnson syndrome or revision surgeries. Avoiding donor-site morbidity enhances overall patient experience and surgical efficiency.

Conclusion

Cryopreserved amniotic membrane transplantation represents a versatile and biologically active tool in oculoplastic surgery, offering superior outcomes in eyelid and orbital reconstruction. Its unique properties and handling characteristics make it preferable to traditional grafts for complex cases.

References

1. BioTissue Ocular FDA Approval 2023 -- CAM360 Product Recognition
2. Clinical Applications of CAM in Oculoplastics 2023 -- Anti-inflammatory and Regenerative Properties
3. Surgical Techniques in CAM Use 2023 -- Fornix Reconstruction and Socket Contracture